GO:1990904 ribonucleoprotein complex: Components, Assembly and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:1990904 (ribonucleoprotein complex) defines any macromolecular assembly that contains both RNA and protein molecules, including RNPs such as the spliceosome, ribosome, CRISPR-Cas effector complexes, and mRNA export machineries.
• The term is a cellular_component ontology annotation, meaning it describes where a gene product localizes rather than a catalytic activity or a biological process.
• Ribonucleoprotein complexes are central to gene expression, RNA processing, RNA export, translation, and genome defense, and their dysfunction is linked to neurodegeneration, cancer, and developmental disorders.
• CRISPR-Cas9 functions as a ribonucleoprotein complex in which the Cas9 protein and a guide RNA together mediate sequence-specific DNA cleavage.
• Delivery of pre-assembled Cas9 ribonucleoprotein complexes enables transient, DNA-free genome editing in cells and in vivo, including lung and liver editing via lipid nanoparticles.
• Studying ribonucleoprotein complexes requires integrated methods such as cell-free extract reconstitution, single-molecule imaging, RNA-seq, proteomics, and CRISPR-based perturbation.
Description
GO:1990904, ribonucleoprotein complex, is a Gene Ontology cellular_component term that describes a macromolecular complex containing both RNA and protein molecules. Such complexes are ubiquitous in cells and perform essential roles in RNA processing, RNA export, translation, and genome defense. The spliceosome, for example, is a dynamic ribonucleoprotein machine that catalyzes pre-mRNA splicing, and its structure and function have been extensively characterized. Similarly, the human transcription-export (TREX) complex recognizes and packages mRNA into export-competent ribonucleoprotein particles. Because these assemblies combine RNA and protein components, they are often studied as integrated machines rather than as isolated molecules. For researchers, GO:1990904 provides a standardized way to annotate gene products that localize to or function within RNA-protein assemblies. The term encompasses both intracellular and extracellular ribonucleoprotein complexes, as well as protein-RNA complexes more broadly. This breadth reflects the diversity of RNPs, from the CRISPR-Cas9 effector complex used in genome editing to neuronal RNPs that influence protein homeostasis in the aging brain. Understanding how these complexes assemble, recognize their RNA partners, and execute their functions is therefore central to molecular biology and to the development of RNA- and RNP-based therapeutics. Recent advances in cell-free reconstitution and single-molecule imaging have made it possible to dissect ribonucleoprotein complex biology at unprecedented resolution. At the same time, CRISPR-Cas9 ribonucleoprotein delivery has emerged as a powerful strategy for transient genome editing in vivo, including lung and liver editing using lipid nanoparticles. These developments highlight why GO:1990904 remains a key annotation for both basic and translational research.
ribonucleoprotein complex At A Glance
| GO ID | GO:1990904 |
|---|---|
| GO term | ribonucleoprotein complex |
| Ontology | cellular_component |
| Synonym | extracellular ribonucleoprotein complex; intracellular ribonucleoprotein complex; protein-RNA complex; RNA-protein complex; RNP |
| Major function | Macromolecular assembly containing both RNA and protein molecules that carries out RNA processing, RNA export, translation, or genome defense |
| Example complexes | Spliceosome, TREX complex, CRISPR-Cas9 effector complex, neuronal C1q-containing RNPs |
| Research relevance | Central to gene expression, RNA metabolism, genome editing, and disease mechanisms |
| Related methods | Cell-free reconstitution, single-molecule imaging, RNA-seq, proteomics, CRISPR-Cas9 RNP delivery |
What Is GO:1990904?
In the Gene Ontology, GO:1990904 (ribonucleoprotein complex) is defined as a macromolecular complex that contains both RNA and protein molecules. It is classified under the cellular_component ontology, meaning it describes a cellular structure or location rather than a molecular function or biological process. Synonyms include extracellular ribonucleoprotein complex, intracellular ribonucleoprotein complex, protein-RNA complex, RNA-protein complex, and RNP. The term is intentionally broad and covers assemblies ranging from the spliceosome and ribosome to CRISPR-Cas effector complexes and mRNA export particles.
Why Is ribonucleoprotein complex Important in Cell Biology?
GO:1990904 is important because ribonucleoprotein complexes are the physical machines that execute many core steps of gene expression and RNA regulation. The spliceosome, a ribonucleoprotein complex, catalyzes pre-mRNA splicing, and the TREX complex packages mRNA into export-competent particles. In genome defense, the CRISPR-Cas9 effector is itself a ribonucleoprotein complex in which the Cas9 protein and guide RNA collaborate to cleave DNA. Beyond these examples, neuronal ribonucleoprotein complexes can integrate complement proteins such as C1q and influence protein homeostasis in the aging brain. Because RNPs are so central, their dysfunction is associated with a wide range of human diseases, and their programmable nature makes them attractive targets for therapeutic genome editing.
• Ribonucleoprotein complexes such as the spliceosome are essential for pre-mRNA splicing and gene expression.
• The TREX complex recognizes and packages mRNA into export-competent ribonucleoprotein particles.
• CRISPR-Cas9 functions as a ribonucleoprotein complex that mediates sequence-specific DNA cleavage.
• Delivery of Cas9 ribonucleoprotein complexes enables transient, DNA-free genome editing in cells and in vivo.
• Lipid nanoparticle delivery of stable CRISPR-Cas9 ribonucleoprotein enables lung and liver editing.
• Neuronal ribonucleoprotein complexes can incorporate microglial-derived C1q and impact protein homeostasis in the aging brain.
• Cell-free extracts and single-molecule imaging allow detailed dissection of RNP assembly and function.
• Dysfunction of ribonucleoprotein complexes is linked to neurodegeneration, cancer, and developmental disorders.
• RNP-based delivery is a promising strategy for therapeutic genome editing.
• GO:1990904 provides a standardized annotation for genes whose products localize to RNA-protein assemblies.
What Happens During ribonucleoprotein complex?
Assembly of RNA and protein components
In simple terms: RNA and proteins come together to form a working machine.
Ribonucleoprotein complexes assemble when RNA molecules and proteins interact to form a macromolecular assembly. In the spliceosome, small nuclear RNAs and numerous proteins assemble into a dynamic machine that catalyzes splicing. In the CRISPR-Cas9 system, the Cas9 protein binds a guide RNA to form a ribonucleoprotein complex capable of specific DNA cleavage. The TREX complex recognizes mRNA and packages it into an export-competent ribonucleoprotein particle. These examples illustrate that assembly is often guided by RNA sequence or structure and by protein-RNA interaction domains.
RNA recognition and substrate engagement
In simple terms: The complex finds and grabs its RNA target.
Many ribonucleoprotein complexes must recognize specific RNA sequences or structures to carry out their functions. The spliceosome engages pre-mRNA at splice sites through base-pairing interactions with small nuclear RNAs and protein factors. The human transcription-export complex recognizes mRNA and packages it for nuclear export. In CRISPR-Cas9, the guide RNA directs the Cas9 ribonucleoprotein complex to a complementary DNA target, illustrating how RNA can program target recognition. These recognition events are often regulated and can be studied using cell-free extracts and single-molecule approaches.
Catalysis and functional output
In simple terms: The complex does its job, such as cutting RNA or DNA.
Once assembled and engaged with its substrate, a ribonucleoprotein complex catalyzes a specific reaction or performs a structural role. The spliceosome catalyzes the two transesterification reactions of pre-mRNA splicing. The Cas9 ribonucleoprotein complex cleaves DNA at a site determined by the guide RNA. The TREX complex facilitates mRNA export rather than catalysis, showing that RNPs can have structural or transport functions. These diverse outputs highlight the functional versatility of GO:1990904.
Disassembly and recycling
In simple terms: The machine comes apart after it finishes.
After completing their function, ribonucleoprotein complexes are often disassembled and their components recycled. The spliceosome undergoes extensive remodeling and disassembly during each round of splicing. In CRISPR-Cas9, the ribonucleoprotein complex can be degraded or diluted after DNA cleavage, which contributes to transient editing. Understanding disassembly is important for designing RNP-based therapeutics with controlled activity.
Key Genes Involved in GO:1990904 ribonucleoprotein complex
The following genes and proteins are representative components or functional partners of ribonucleoprotein complexes (GO:1990904) and are widely studied in RNA biology and genome editing.
| Gene | Major Role | Research Relevance |
|---|---|---|
| CAS9 | RNA-guided DNA endonuclease that forms a ribonucleoprotein complex with guide RNA | Core effector for CRISPR genome editing and RNP delivery |
| C1Q | Complement protein that can integrate into neuronal ribonucleoprotein complexes | Links neuroimmune signaling to RNP function in aging brain |
| TREX | Transcription-export complex that packages mRNA into ribonucleoprotein particles | Model for mRNA recognition and nuclear export |
| SNRNP | Small nuclear ribonucleoproteins that form the spliceosome | Central to pre-mRNA splicing and spliceosome assembly |
| DDX | RNA helicases that remodel ribonucleoprotein complexes | Regulate RNP assembly and dynamics |
| HNRNP | Heterogeneous nuclear ribonucleoproteins that bind pre-mRNA | Key players in RNA processing and export |
| EIF | Eukaryotic initiation factors that form translation initiation complexes | Control translation initiation and RNP assembly |
| RPL | Ribosomal proteins that assemble with rRNA into ribosomes | Model for ribosome biogenesis and translation |
| RPS | Ribosomal proteins of the small subunit | Study of translation and ribosomopathies |
| NUP | Nucleoporins that interact with export-competent RNPs | Nuclear export and RNP trafficking |
| SR | Serine/arginine-rich proteins that regulate splicing | Spliceosome regulation and alternative splicing |
| PTBP1 | Polypyrimidine tract-binding protein involved in RNA processing | Model for RNP-mediated splicing regulation |
| FUS | RNA-binding protein that forms ribonucleoprotein complexes | Linked to neurodegeneration and RNP biology |
| TDP43 | RNA-binding protein that assembles into RNPs | Implicated in ALS and RNP dysfunction |
| STAU1 | Double-stranded RNA-binding protein in RNPs | mRNA transport and stability |
| IGF2BP | RNA-binding protein that packages mRNA into RNPs | mRNA localization and translation |
| CASC3 | Exon junction complex component | mRNA packaging and export |
How Is ribonucleoprotein complex Regulated?
Ribonucleoprotein complex assembly and activity are regulated at multiple levels. RNA helicases and other remodeling factors use ATP to rearrange RNA-protein interactions during spliceosome assembly and disassembly. The TREX complex is recruited to mRNA in a transcription-coupled manner and is regulated by interactions with nuclear export factors. In CRISPR-Cas9, the guide RNA sequence and chemical modifications influence RNP stability and targeting specificity. Delivery methods, such as lipid nanoparticles, can also control the duration and tissue distribution of Cas9 ribonucleoprotein activity. Cell-free systems and single-molecule assays have been used to dissect these regulatory steps in real time.
ribonucleoprotein complex and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| C1Q | Aging brain and protein homeostasis | Knockout or tagged knock-in in neuronal cells |
| FUS | Neurodegeneration and RNP dysfunction | Point mutation or knockout in iPSC-derived neurons |
| TDP43 | ALS and RNP pathology | Overexpression or knockout in neuronal models |
| CAS9 | Genome editing therapeutics | RNP delivery in cell lines and mouse models |
| SNRNP | Cancer and splicing dysregulation | Knockout or point mutation in cancer cell lines |
Neurodegeneration and RNP dysfunction
Ribonucleoprotein complexes are increasingly implicated in neurodegenerative disease. Microglial-derived C1q integrates into neuronal ribonucleoprotein complexes and impacts protein homeostasis in the aging brain, suggesting a link between neuroimmune signaling and RNP function. RNA-binding proteins such as FUS and TDP43 form ribonucleoprotein complexes, and their dysfunction is associated with neurodegeneration. These findings highlight GO:1990904 as a relevant annotation for genes involved in age-related brain disorders.
Cancer and RNA processing
Dysregulation of ribonucleoprotein complexes can contribute to cancer through altered RNA processing, export, and translation. The spliceosome is a ribonucleoprotein complex that catalyzes pre-mRNA splicing, and its components are frequently mutated or overexpressed in cancers. The TREX complex packages mRNA into export-competent particles, and its dysfunction can affect gene expression programs relevant to tumor biology. Studying these complexes may reveal therapeutic vulnerabilities.
Ribosomopathies and translation defects
Ribosomes are ribonucleoprotein complexes composed of ribosomal RNA and ribosomal proteins. Mutations affecting ribosomal proteins or assembly factors can cause ribosomopathies, a group of disorders characterized by defective translation and tissue-specific phenotypes. GO:1990904 provides a framework for annotating genes involved in ribosome biogenesis and function.
Therapeutic genome editing with RNPs
CRISPR-Cas9 ribonucleoprotein complexes are being developed as therapeutic agents for genome editing. Delivery of pre-assembled Cas9 RNPs enables transient editing and reduces off-target effects compared with plasmid-based approaches. Lipid nanoparticle delivery of stable CRISPR-Cas9 ribonucleoprotein has achieved lung and liver editing in vivo, demonstrating the translational potential of RNP-based therapeutics. These applications underscore the importance of understanding RNP biology for medicine.
From ribonucleoprotein complex-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does a candidate gene localize to ribonucleoprotein complexes? | Tagged knock-in with fluorescent or affinity tag |
| Is a specific RNA-binding domain required for RNP assembly? | Point mutation of the RNA-binding domain |
| What is the loss-of-function phenotype of an RNP component? | CRISPR knockout cell line |
| Can a disease-associated mutation alter RNP function? | Knock-in of the patient mutation |
| Does overexpression of an RNP protein drive disease phenotypes? | Overexpression cell model |
| Can Cas9 RNP edit a target gene in vivo? | Lipid nanoparticle delivery in mouse models |
How to Study the ribonucleoprotein complex Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Cell-free reconstitution | Assembly and activity of RNPs in vitro | Mechanistic studies of spliceosome or Cas9 |
| Single-molecule imaging | Real-time dynamics of RNP components | RNA recognition and catalysis |
| RNA-seq | RNA species associated with RNPs | mRNA packaging and export |
| Proteomics | Protein composition of RNPs | Interactome mapping |
| CRISPR-Cas9 RNP delivery | Editing efficiency and specificity | Therapeutic genome editing |
| Lipid nanoparticle delivery | In vivo editing in lung and liver | Tissue-specific genome editing |
| Electrophoretic mobility shift assay | RNA-protein binding affinity | Characterization of RNP assembly |
| Immunoprecipitation | RNP components and associated RNAs | Neuronal RNP studies |
Cell-free reconstitution and single-molecule imaging
Functional cell-free extracts can be used to dissect ribonucleoprotein complex biology at single-molecule resolution. These systems allow controlled assembly of RNPs from purified components and real-time observation of RNA recognition and catalysis. They are particularly useful for studying dynamic complexes such as the spliceosome and CRISPR-Cas9.
RNA sequencing and RNP profiling
RNA-seq and related approaches can identify RNAs associated with specific ribonucleoprotein complexes. The TREX complex, for example, was studied to understand how mRNA is recognized and packaged. These methods help define the RNA repertoire of an RNP and its role in gene expression.
Proteomics and interactome analysis
Mass spectrometry-based proteomics can identify protein components of ribonucleoprotein complexes. Affinity purification of tagged RNP components followed by proteomics reveals interaction partners and assembly intermediates. This is essential for defining the composition of complexes annotated under GO:1990904.
CRISPR-Cas9 RNP delivery and editing assays
CRISPR-Cas9 ribonucleoprotein complexes can be delivered to cells and tissues using electroporation or lipid nanoparticles. Editing outcomes are measured by sequencing, and delivery methods are optimized for specific tissues such as lung and liver. These assays are central to therapeutic development.
How CRISPR Can Be Used to Study GO:1990904 ribonucleoprotein complex
Knockout
CRISPR knockout can be used to eliminate a candidate gene and test whether it is required for ribonucleoprotein complex assembly or function. For example, knocking out an RNP component can reveal its role in RNA processing or translation. Knockout models are also used to study disease-associated RNP genes.
Point Mutation
Point mutations can be introduced to dissect specific domains or residues within RNP proteins. For instance, mutating an RNA-binding motif can test its contribution to RNP assembly. Point mutations can also model patient-derived variants in RNP genes.
Knock-in
Knock-in of tags or disease alleles allows visualization and functional analysis of ribonucleoprotein complexes in their native context. Fluorescent tags enable imaging of RNP localization, while disease alleles can reveal pathogenic mechanisms. Knock-in models are valuable for studying RNP dynamics.
Overexpression
Overexpression of RNP components can be used to test gain-of-function effects and to produce sufficient material for biochemical studies. Overexpression of RNA-binding proteins such as FUS or TDP43 can model neurodegeneration-associated RNP dysfunction. It is also used to study mRNA packaging by complexes like TREX.
How EDITGENE Supports ribonucleoprotein complex Research
Researchers studying ribonucleoprotein complex-related genes often need to determine whether a candidate gene is causally involved in RNP assembly, function, or disease. EDITGENE provides a comprehensive suite of CRISPR services to enable such studies, from knockout and point mutation to knock-in, overexpression, and library screening.
Contact EDITGENE today to design your custom CRISPR model for ribonucleoprotein complex research.
Frequently Asked Questions About ribonucleoprotein complex
What is GO:1990904?
GO:1990904 is the Gene Ontology term for ribonucleoprotein complex, defined as a macromolecular complex that contains both RNA and protein molecules.
What is a ribonucleoprotein complex?
A ribonucleoprotein complex is an assembly of RNA and proteins that performs functions such as RNA processing, export, translation, or genome defense.
What genes are involved in ribonucleoprotein complexes?
Genes encoding RNA-binding proteins, spliceosomal components, ribosomal proteins, and CRISPR-Cas9 effectors are involved in ribonucleoprotein complexes.
What is the function of the ribonucleoprotein complex?
Ribonucleoprotein complexes carry out diverse functions including pre-mRNA splicing, mRNA export, translation, and DNA cleavage by CRISPR-Cas9.
How are ribonucleoprotein complexes studied?
They are studied using cell-free reconstitution, single-molecule imaging, RNA-seq, proteomics, and CRISPR-based perturbation.
What diseases are linked to ribonucleoprotein complexes?
Dysfunction of ribonucleoprotein complexes is linked to neurodegeneration, cancer, and ribosomopathies.
What is a Cas9 ribonucleoprotein complex?
A Cas9 ribonucleoprotein complex consists of the Cas9 protein and a guide RNA and mediates sequence-specific DNA cleavage.
How is CRISPR-Cas9 ribonucleoprotein delivered?
CRISPR-Cas9 ribonucleoprotein can be delivered by electroporation or lipid nanoparticles for in vivo editing.
What is the role of C1q in ribonucleoprotein complexes?
Microglial-derived C1q can integrate into neuronal ribonucleoprotein complexes and impact protein homeostasis in the aging brain.
What is the TREX complex?
The TREX complex is a ribonucleoprotein complex that recognizes and packages mRNA for nuclear export.
Conclusion
GO:1990904 (ribonucleoprotein complex) is a fundamental cellular_component term that captures the many RNA-protein assemblies essential for gene expression and genome defense. From the spliceosome to CRISPR-Cas9, these complexes perform diverse functions and are increasingly recognized as key players in human disease and therapeutic genome editing. Continued research using cell-free systems, single-molecule imaging, and CRISPR-based models will further illuminate their mechanisms and translational potential.
References
- 1. Gasiunas G et al.. 2012. Cas9-crRNA ribonucleoprotein complex mediates specific DNA cleavage for adaptive immunity in bacteria.. Proc Natl Acad Sci U S A 109(39):E2579-86 PMID: 22949671
- 2. Campbell LA et al.. 2019. Cas9 Ribonucleoprotein Complex Delivery: Methods and Applications for Neuroinflammation.. J Neuroimmune Pharmacol 14(4):565-577 PMID: 31172397
- 3. Bykonya AG et al.. 2023. Methods for CRISPR-Cas as Ribonucleoprotein Complex Delivery In Vivo.. Mol Biotechnol 65(2):181-195 PMID: 35322386
- 4. Will CL et al.. 2011. Spliceosome structure and function.. Cold Spring Harb Perspect Biol 3(7) PMID: 21441581
- 5. Scott-Hewitt N et al.. 2024. Microglial-derived C1q integrates into neuronal ribonucleoprotein complexes and impacts protein homeostasis in the aging brain.. Cell 187(16):4193-4212.e24 PMID: 38942014
- 6. Pacheco-Fiallos B et al.. 2023. mRNA recognition and packaging by the human transcription-export complex.. Nature 616(7958):828-835 PMID: 37020021
- 7. Duran E et al.. 2023. Utilizing functional cell-free extracts to dissect ribonucleoprotein complex biology at single-molecule resolution.. Wiley Interdiscip Rev RNA 14(5):e1787 PMID: 37042458
- 8. Chen K et al.. 2025. Lung and liver editing by lipid nanoparticle delivery of a stable CRISPR-Cas9 ribonucleoprotein.. Nat Biotechnol 43(9):1445-1457 PMID: 39415058
